Shayeganmehr, Delaram
Ramezannia, Fatemeh
Gharib, Behrooz
Rezaeilaal, Azin
Shahi, Farhad
Jafariazar, Zahra
Afshar, Minoo https://orcid.org/0000-0002-7209-9893
Article History
Received: 15 September 2022
Accepted: 10 November 2022
First Online: 24 November 2022
Declarations
:
: The ex vivo experimental protocol was approved by the Local Animal Ethical Committee of Azad University, Faculty of Pharmacy (IR.IAU.PS.REC.1396.111). The Local Ethics Committee of Azad University, Faculty of Pharmacy (IR.IAU.PS.REC.1398.339) approved the applied intra-patient, randomized, double-blind, placebo-controlled clinical trial. All participants provided written informed consent before participating in this study. Patients were permitted to withdraw from the trial at any stage of the investigation without any obligation.
: There author declare no competing interests.